Johannes Rothlind

Johannes Rothlind, PhD, is a Professor in Psychiatry at the University of California, San Francisco (UCSF) School of Medicine, affiliated with the UCSF Weill Institute for Neurosciences. His research focuses on neurology, psychiatry, and cognitive neuroscience, particularly in neurodegenerative diseases and substance-related disorders.

Education includes training at UCSF and a 2019 Diversity, Equity, and Inclusion Champion Training certification. His work spans deep brain stimulation (DBS) for Parkinson’s and Huntington’s diseases, cognitive decline, and the impact of substance use on neurocognition in HIV patients.

Recent publications highlight trends in DBS outcomes, cognitive self-appraisal mechanisms, telemedicine applications for rural elders, and neurotoxic effects of low-level sarin exposure. His studies often intersect with clinical trials, neuroimaging, and behavioral health interventions.

Networks include collaborations with the CSP-468 Study Group, co-authors like Dieter Meyerhoff and Philip Starr, and leadership in neurodegenerative disease research. Grants and specific funding sources are not explicitly mentioned, but his work is widely cited in PubMed and Mendeley.

Labs and teams involve the UCSF Weill Institute for Neurosciences and interdisciplinary groups focused on neurology, psychiatry, and HIV-related cognitive disorders.